Tenet Healthcare (THC) furnishes Q3 2025 results press release

Tenet Healthcare Corporation furnished a Form 8-K under Item 2.02 to announce it issued a press release with financial results for the quarter ended September 30, 2025.

Rhea-AI Filing Summary

Tenet Healthcare Corporation furnished a Form 8-K under Item 2.02 to announce it issued a press release with financial results for the quarter ended September 30, 2025. The company attached the release as Exhibit 99.1 and incorporated it by reference.

The information was furnished, not filed, under the Exchange Act. Tenet lists its securities as common stock (THC) and 6.875% Senior Notes due 2031 (THC31).

8-K Event Classification

Item 2.02 — Results of Operations and Financial Condition

1 item

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Tenet Healthcare (THC) announce in this 8-K?

It furnished an Item 2.02 Form 8-K noting a press release with financial results for the quarter ended September 30, 2025.

Which exhibit contains Tenet Healthcare’s Q3 2025 results?

The press release is attached as Exhibit 99.1 and incorporated by reference.

Is the information in this 8-K considered filed or furnished?

It is furnished under Item 2.02 and not deemed filed under the Exchange Act.

What period do the reported results cover for THC?

The quarter ended September 30, 2025.

What securities does Tenet list in this report?

Common stock (THC) and 6.875% Senior Notes due 2031 (THC31) on the NYSE.

When was the report dated?

The report is dated October 28, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/28/2025 - 06:46 AM Learn about SEC filing dates

0000070318false00000703182025-10-282025-10-280000070318exch:XNYSus-gaap:CommonStockMember2025-10-282025-10-280000070318exch:XNYSus-gaap:SeniorNotesMember2025-10-282025-10-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 _______________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 _______________

Date of Report: October 28, 2025

(Date of earliest event reported)

 _______________

TENET HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

Nevada

1-7293

95-2557091

(State of Incorporation)

(Commission File Number)

(IRS Employer Identification Number)

14201 Dallas Parkway

Dallas, TX 75254

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.05 par value

THC

NYSE

6.875% Senior Notes due 2031

THC31

NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

The information contained herein is being furnished pursuant to Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On October 28, 2025, Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of the Company for the quarter ended September 30, 2025. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits

Exhibit No.						Description
99.1						Press Release issued on October 28, 2025
104						Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						TENET HEALTHCARE CORPORATION
Date: October 28, 2025			By:			/s/ R. SCOTT RAMSEY
						R. Scott Ramsey
						Senior Vice President, Controller